About this trial
The goal of this study is to show a significant difference in performance between 2 groups of participants (healthy elderly people vs. people with Alzheimer Disease) in an identification and naming task involving famous monuments.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age ≥ 50 years and older
Possible or probable diagnosis of Alzheimer's disease according to the revised criteria of Mac Khann et al., 2011.
Score 18≤ MMSE ≤26
Age ≥ 50 years and older
Disqualifiers
Persons referred to in Articles L1121-5 to L1121-8 of the CSP
Memory complaints
Persons referred to in Articles L1121-5 to L1121-8 of the CSP For all subjects
Significant neurological or psychiatric history
Trial population
Participants in the MA group will be selected from among patients attending memory consultations at the CMRR at the CHU Grenoble-Alpes (active file within the department) or from among patients referred to the CMRR by a doctor not practicing at the CMRR (general practitioners or specialists such as neurologists). Healthy elderly participants will be recruited from among those accompanying patients being monitored at the CMRR.
Trial design
Cohort
Prospective
Treatments tested in this trial
Identification and naming task
Other interventionTask of identification and naming of landmarks and celebrities
Treatment groups
Trial outcomes
Primary outcomes
Difference between the two groups in the identification and naming task involving famous landmarks
show a significant difference in performance between the two groups in the identification and naming task involving famous landmarks
Secondary outcomes
Development and standardization of a new tool for screening for naming disorders and visual identification of unique entities.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.